Spectral AI, Inc.
NASDAQ:MDAI · NASDAQ Capital Market
+$0.01 today
Vol 0.49M · Avg 1.00M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
132.2%
avg 251.7%
ROIC
-197.0%
avg 517.2%
ROA
-35.4%
avg -65.7%
Analysis
ROE is currently the strongest return metric at 132.2% versus its period average of 251.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Wensheng Fan | Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer | $1.25M | — | 56 | $0.00 | <0.01% |
Vincent Stanley Capone | CEO & Corporate Secretary | $733,515.00 | — | 59 | $286,450.00 | 0.90% |
David McGuire | Chief Financial Officer | $479,814.00 | — | 47 | — | — |
Stan Micek | Chief Operating Officer | $468,000.00 | — | 64 | $10,000.00 | 0.03% |
Louis Percoco | General Manager | $422,730.00 | — | 66 | — | — |
John Michael DiMaio | Founder & Chairman | $200,000.00 | — | 70 | $2.69M | 8.45% |
Allison Kumar | Head of Regulatory Affairs & Clinical Trials | — | — | 48 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | -8.2% | -1.5% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -8.2% over three years. Forward estimates point to Revenue at -1.5% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$208.27M
Century Therapeutics, Inc.
NASDAQ:IPSC
$197.81M
Equillium, Inc.
NASDAQ:EQ
$107.81M
electroCore, Inc.
NASDAQ:ECOR
$67.69M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
Telomir Pharmaceuticals, Inc. Common Stock
TELO
$46.11M
Sensus Healthcare, Inc.
SRTS
$45.19M
TELA Bio, Inc.
TELA
$35.81M
Cytosorbents Corporation
CTSO
$29.31M
IceCure Medical Ltd
ICCM
$12.61M
Who manages MDAI?
Spectral AI, Inc. (MDAI) lists 7 active executives. The top listed executive is Louis Percoco, General Manager.
Are MDAI insiders buying or selling?
Recent insider activity shows net buying of $4.59M.
Explore More
Continue the stock analysis
Jump to another research area for this company.